In-transit melanoma: An individualized approach

Travis E. Grotz, Aaron S. Mansfield, Lisa A. Kottschade, Lori A. Erickson, Lori A. Erickson, Svetomir N. Markovic, James W. Jakub

Research output: Contribution to journalComment/debate

21 Scopus citations


The majority of locoregional recurrences in melanoma occur in the form of intradermal or subcutaneous local or in-transit metastasis. In-transit melanoma represents contamination of the lymphatic space that, if treated, can result in long-term cure in a subset of patients. The management of in-transit metastases is challenging, since the treatments and extent of disease vary greatly based on the number, depth, location, and distribution of lesions, and on their biological behavior. A number of different treatment options exist, but there is no level 1 evidence to guide clinical decision-making. Herein we present our institutional treatment algorithm, which allows for individualization based on the patient's presentation.

Original languageEnglish (US)
Article number7
Issue number14
StatePublished - Dec 1 2011

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'In-transit melanoma: An individualized approach'. Together they form a unique fingerprint.

  • Cite this

    Grotz, T. E., Mansfield, A. S., Kottschade, L. A., Erickson, L. A., Erickson, L. A., Markovic, S. N., & Jakub, J. W. (2011). In-transit melanoma: An individualized approach. Oncology, 25(14), [7].